TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTION
TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTION
批准号:
6440494
负责人:
MARTIN M. MATZUK
金额:
$17.42万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-01 至 2002-03-31
中文摘要
哺乳动物的繁殖是一个复杂的过程,需要
下丘脑、垂体和卵巢水平的多种因素和
睾丸。胚胎干细胞及其转基因研究进展
鼠标技术使调查人员能够解决关键问题
这些因子中的几个在体内的作用。了解卵巢
功能,我们创造了重要的转基因小鼠模型
生长分化因子9(GDF-9)、卵泡刺激素
卵泡刺激素(FSH)、激活素受体II型(ActRII)和生殖细胞核因子
(GCNF)。缺乏GDF-9、FSH和ActRII的雌性小鼠由于
对处于卵泡发育特定阶段的黑人来说。相比之下,GCNF-
缺陷小鼠因GCNF在妊娠中期的重要作用而死亡
胎盘的胚胎外发育。GCNF是以下组织的孤儿成员
核受体超家族在发育中的生殖细胞中的表达
成年老鼠。在卵母细胞中,GCNF从一层开始表达
初级卵泡期通过排卵类似于转化生长因子-β家族
成员,GDF-9。此外,我们最近还发现了另一种转化生长因子-β
家族成员,小说1,具有卵母细胞特异性表达模式
类似于GDF-9和GCNF。GCNF和NOVICE的功能特征
在卵巢发育期间,我们将产生几个新的转基因
老鼠线。这些研究的具体目的如下:1)
鉴定新基因1在小鼠卵巢发育中的作用;2)研究
GCNF在卵母细胞成熟中的生理作用;3)分析
小鼠和人卵母细胞和生殖细胞中GCNF和新型1基因的调控
肿瘤;以及4)使用具有多个缺陷和mRNA的转基因小鼠
用表达分析来确定几个基因的相互作用
产品涉及卵巢发育和功能。
上述研究将评估这些基因的重要作用。
在卵巢发育过程中。我们假设新的1基因缺陷小鼠
具有卵巢特异性GCNF基因敲除的小鼠将是继发性不孕
到卵泡发生的早期障碍。如果这一假设是真的,那么这些
突变的雌性小鼠表现出生育缺陷,GCNF和新的1可能是
新型避孕药的潜在靶点和人类的治疗
不孕不育。
英文摘要
Mammalian reproduction is a complex process requiring the interaction of
multiple factors at the levels of hypothalamus, pituitary, and ovaries and
testes. The rapid advances in embryonic stem (ES) cell and transgenic
mouse technology have allowed investigators to address the essential
functions of several of these factors in vivo. To understand ovarian
function, we have created important transgenic mouse models deficient in
growth differentiation factor 9 (GDF-9), follicle stimulating hormone
(FSH), activin receptor type II (ActRII), and germ cell nuclear factor
(GCNF). Female mice deficient in GDF-9, FSH, and ActRII are infertile due
to blacks at specific stages of folliculogenesis. In contrast, GCNF-
deficient mice die at mid-gestation due to important role of GCNF during
extraembryonic development of the placenta. GCNF is an orphan member of
the nuclear receptor superfamily expressed in the developing germ cells of
the adult mouse. In the oocyte, GCNF is expressed from the one layer
primary follicle stage through ovulation similar to the TGF-beta family
member, GDF-9. In addition, we have recently identified another TGF-beta
family member, Novel 1, which has a pattern of oocyte-specific expression
similar to GDF-9 and GCNF. To characterize the functions of GCNF and Novel
1 during ovarian development, we will generate several new transgenic
mouse lines. The Specific Aims of these studies are as follows: 1)
Characterize the role of Novel 1 in mouse ovarian development; 2) Study
the physiological function of GCNF in oocyte maturation; 3) Analyze the
regulation of GCNF and Novel 1 in mouse and human oocytes and germ cell
tumors; and 4) Use transgenic mice with multiple defects and mRNA
expression analysis to define the interrelated roles of several gene
products in ovarian development and function.
The above-mentioned studies will assess the important roles of these genes
in ovarian development. We hypothesize that Novel 1-deficient mice and
mice with an ovary-specific knockout of GCNF will be infertile secondary
to early blocks in folliculogenesis. If this hypothesis is true and these
mutant female mice exhibit fertility defects, GCNF and Novel 1 may be
potential targets for new contraceptive agents and treatment of human
infertility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kinases as Therapeutic Targets for Endometriosis
-
批准号:10674987
-
项目类别:
-
资助金额:$68.77万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
-
批准号:10682061
-
项目类别:
-
资助金额:$64.52万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
-
批准号:10764639
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
-
批准号:10419647
-
项目类别:
-
资助金额:$10.15万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
-
批准号:10598585
-
项目类别:
-
资助金额:$70.24万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Kinases as Therapeutic Targets for Endometriosis
-
批准号:10532966
-
项目类别:
-
资助金额:$68.77万
-
财政年份:2022
-
负责人:MARTIN M. MATZUK
-
依托单位:
Targeting testis-specific ubiquitin-proteasome pathways for male contraception
-
批准号:10018522
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2019
-
负责人:MARTIN M. MATZUK
-
依托单位:
Functional genomics and DEC-Tec to identify germ cell-specific contraceptives
-
批准号:10164823
-
项目类别:
-
资助金额:$121.0万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Administrative Core
-
批准号:9278437
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Administrative Core
-
批准号:10164824
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Targeting sperm-specific proteins during meiosis and sperm morphogenesis
-
批准号:10164826
-
项目类别:
-
资助金额:$27.86万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Targeting sperm-specific proteins during meiosis and sperm morphogenesis
-
批准号:9278439
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2017
-
负责人:MARTIN M. MATZUK
-
依托单位:
Functional analysis of novel testis-expressed secreted and transmembrane proteins
-
批准号:10597610
-
项目类别:
-
资助金额:$49.42万
-
财政年份:2016
-
负责人:MARTIN M. MATZUK
-
依托单位:
Functional analysis of novel testis-expressed secreted and transmembrane proteins
-
批准号:10378949
-
项目类别:
-
资助金额:$50.92万
-
财政年份:2016
-
负责人:MARTIN M. MATZUK
-
依托单位:
Functional analysis of novel testis-expressed secreted and transmembrane proteins
-
批准号:9324300
-
项目类别:
-
资助金额:$39.29万
-
财政年份:2016
-
负责人:MARTIN M. MATZUK
-
依托单位:
Mouse Models to Study Gonadal Tumor Development
-
批准号:7914962
-
项目类别:
-
资助金额:$5.29万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
Defining the Mammalian Intercellular Bridge Interactome
-
批准号:7582169
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
ANALYSIS OF REPRODUCTIVE FUNCTION USING TRANSGENIC MICE
-
批准号:7935154
-
项目类别:
-
资助金额:$13.6万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
identification of small molecule contraceptives that target the male germline
-
批准号:8223290
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
identification of small molecule contraceptives that target the male germline
-
批准号:8064005
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2009
-
负责人:MARTIN M. MATZUK
-
依托单位:
海外基金